BioCardia to Present 2025 Financial Results and Corporate Update on March 24, 2026

jueves, 19 de marzo de 2026, 7:49 pm ET1 min de lectura
BCDA--

BioCardia will host a conference call on March 24, 2026, to discuss its 2025 financial results and provide a corporate update. The call will be available through a live webcast and a telephonic replay will also be available. BioCardia is a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases.

BioCardia to Present 2025 Financial Results and Corporate Update on March 24, 2026

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios